NEWARK, Calif., Nov. 11, 2013 (GLOBE NEWSWIRE) -- CellScape Inc. today announced that Co-Founder and Executive Chair Karen Drexler has been named the winner of a Gold Stevie® Award for Female Entrepreneur of the Year in the business services segment with 11 to 2,500 employees in the 10 th annual Stevie Awards for Women in Business.
The Stevie Awards for Women in Business are the world's top honors for female entrepreneurs, executives, employees and the organizations they run. All individuals and organizations worldwide are eligible to submit nominations – public and private, for-profit and non-profit, large and small. The 2013 awards received entries from 18 nations and territories. More than 1,200 nominations from organizations of all sizes and in virtually every industry were submitted this year.
"I am honored to accept and share this award with Co-Founder and Chief Technology Officer, Bhairavi Parikh, who has been instrumental in establishing CellScape and developing our Clarity™ Prenatal Genetic Test. CellScape was founded on the vision of making comprehensive and safe prenatal genetic testing available to every woman," said Karen Drexler, CellScape Co-Founder & Executive Chair. "We would like to thank the Stevie Awards selection committee for acknowledging our efforts over the past several years."
Stevie Award winners were selected by more than 240 executives worldwide who participated in the judging process this year.
About the Stevie Awards
Stevie Awards are conferred in five programs: the Asia-Pacific Stevie Awards, The International Business Awards, The American Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about The Stevie Awards at www.StevieAwards.com .
About CellScape Corporation
CellScape Corporation is an innovative molecular diagnostics company developing a more comprehensive and safe prenatal testing solution for women. CellScape's proprietary Fetal Cell Technology enables it to isolate fetal cells specific to a woman's current pregnancy from a simple maternal blood draw. By isolating these cells, CellScape can access the pure and complete fetal genome. CellScape's first product in development, Clarity™ Prenatal Genetic test, will use targeted Chromosomal Microarray Analysis (CMA) to detect prenatally relevant cytogenetic abnormalities. For additional information, please visit www.cellscapecorp.com .
David Carey/Tanner Kaufman Lazar Partners Ltd. 212 867 1768
